3rd Quarter - Report

ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 184 (Protect Medical Innovation Act of 2018), all provisions

LobbyistCovered position, as disclosed
DAN RENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 184 (115th)

Veterans VET

Procurement of chronic wound healing products

LobbyistCovered position, as disclosed
JAMES RAVITZ —
DAN RENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare reimbursement policy for chronic wound healing products Implementation of Public Law 115-141 (Consolidated Appropriations Act, 2018), Section 1301, regarding Medicare reimbursement policy for wound healing products

LobbyistCovered position, as disclosed
SONJA NESBIT —
JAMES RAVITZ —
DAN RENBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.